Michael Morrissey
Chief Executive Officer chez EXELIXIS, INC.
Fortune : 59 M $ au 31/03/2024
Profil
Actuellement, Michael M. Morrissey occupe le poste de président, chef de la direction et directeur chez Exelixis, Inc. Le Dr Morrissey est également membre du conseil d'administration de XWPharma Ltd. Au cours de sa carrière antérieure, le Dr Morrissey a occupé le poste de scientifique principal chez Ciba-Geigy Corp. et de vice-président de la recherche sur la découverte chez Berlex Biosciences. Michael M. Morrissey a obtenu un doctorat de l'université de Harvard et un diplôme de premier cycle de l'université du Wisconsin.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EXELIXIS, INC.
0,82% | 23/02/2024 | 2 492 969 ( 0,82% ) | 59 M $ | 31/03/2024 |
| 18/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Michael Morrissey
| Sociétés | Poste | Début |
|---|---|---|
| EXELIXIS, INC. | Chief Executive Officer | 22/07/2010 |
| VERA THERAPEUTICS, INC. | Chairman | 24/05/2022 |
XWPharma Ltd.
 XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Director/Board Member | 16/12/2020 |
Anciens postes connus de Michael Morrissey
| Sociétés | Poste | Fin |
|---|---|---|
CERo Therapeutics, Inc.
 CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Director/Board Member | 01/11/2022 |
| Berlex Biosciences | Corporate Officer/Principal | 01/01/2000 |
| Ciba-Geigy Corp. | Chief Tech/Sci/R&D Officer | 01/01/1991 |
Formation de Michael Morrissey
| Harvard University | Doctorate Degree |
| University of Wisconsin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
| Ciba-Geigy Corp. | Health Technology |
| Berlex Biosciences | |
XWPharma Ltd.
XWPharma Ltd. Pharmaceuticals: MajorHealth Technology Xwpharma operates as a biopharmaceutical company. It focuses on eveloping a portfolio of internally discovered product candidates for the treatment of neurological disorders. The company was founded by Jia-Ning Xiang and is headquartered in Wuhan, China. | Health Technology |
CERo Therapeutics, Inc.
CERo Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services CERo Therapeutics, Inc. operates as a biopharmaceutical company. It offers cell-based therapies that incorporate multiple forms of tumor clearance into single cells. The company was founded by Daniel Mark Corey and Lawrence Corey and is headquartered in South San Francisco, CA. | Commercial Services |
| Vera Therapeutics, Inc. |
